Kelun Pharmaceutical's controlling shareholder adjusts share pledges

Liu Gexin, the controlling shareholder of Sichuan Kelun Pharmaceutical, recently released a total of 36,520,000 shares from pledge. These shares, representing 9.63% of his holdings and 2.29% of the company's total share capital, were pledged to Huatai Securities (Shanghai) Asset Management Co., Ltd. and were released between September 10 and September 11, 2025.

Concurrently, Liu Gexin also pledged an additional 27,500,000 shares to Huatai Securities (Shanghai) Asset Management Co., Ltd. These newly pledged shares, which include high-level executive restricted shares, amount to 7.26% of his total holdings and 1.72% of the company's total share capital, with pledges commencing September 9 and September 10, 2025, and maturing September 1, 2026. As of the latest disclosure, Liu Gexin’s cumulative pledged shares total 94,347,000, representing 24.89% of his total holdings and 5.9% of the company's total share capital.

Furthermore, Sichuan Kelun Pharmaceutical established new dedicated bank accounts for its convertible bond proceeds, totaling RMB 298,005.40, which are being temporarily used to supplement working capital. These accounts are overseen by a four-party regulatory agreement involving the company, its subsidiaries, China Everbright Bank, and Changjiang Securities Underwriting and Sponsoring Co., Ltd., ensuring proper management of the funds.